cupure logo
trumpgazaattackputinukrainetrumpswardronerussiandead

HHS cancels Moderna's $590M bird flu vaccine award

HHS cancels Moderna's $590M bird flu vaccine award
The Trump administration canceled a nearly $600 million award to Moderna to develop an mRNA vaccine for bird flu in humans, the company announced Wednesday.Why it matters: It ends one of the remaining Biden-era efforts aimed at creating vaccines for pandemic preparedness. But the company said it would explore alternatives for further developing and manufacturing the shot.Driving the news: Moderna reported positive early stage data on the mRNA vaccine, saying clinical testing in roughly 300 adults was found to be generally well-tolerated. Participants achieved 98% immunity within three weeks of the second dose of the vaccine, the company said. "While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis of the Phase 1/2 study of our H5 avian flu vaccine and we will explore alternative paths forward for the program," Moderna CEO Stéphane Bancel said in a statement. "These clinical data in pandemic influenza underscore the critical role mRNA technology has played as a countermeasure to emerging health threats."Details: The funds awarded in January from the Biomedical Advanced Research and Development Authority were aimed at creating a line of defense against H5N1 in people that matches the strains circulating in cows and birds.It followed another award to Moderna for bird flu vaccine development worth $176 million that the Biden administration granted in July 2024.Trump administration officials previously told the company it was reviewing all contacts from the prior administration.

Comments

World news